Skip to main content
    S

    Sunshine Biopharma Inc (SBFM)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $2.60
    -0.10 (-3.70%)

    Market Cap: $2.22M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Sunshine Biopharma Inc (SBFM) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Sunshine Biopharma are Redhill Biopharma (RDHL), PRF Technologies (PRFX) and cbdMD (YCBD). By market cap, Sunshine Biopharma ranks 13th of the 13 companies on this page; BioCryst Pharmaceuticals (BCRX) is the largest at $1.96B.

    Peer Comparison

    SBFM's revenue growth of 0.3% is below the peer median of 16.9%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Sunshine Biopharma (SBFM)$2.22MN/AN/A-17.4%N/A0.3%0.00%
    Redhill Biopharma Ltd (RDHL)$3.33MN/AN/A0.0%N/A58.6%0.00%
    PRF Technologies Ltd. (PRFX)$2.74MN/A21.9x0.0%-56.1%0.0%0.00%
    cbdMD Inc (YCBD)$5.02MN/AN/A-13.8%N/A20.6%0.00%
    Sonoma Pharmaceuticals Inc (SNOA)$5.52MN/A0.2x-7.7%-20.9%28.0%0.00%
    Gelteq Limited Ordinary Shares (GELS)$4.07MN/AN/A0.0%N/A48.9%0.00%
    Akanda Corp (AKAN)$3.59MN/A1.8x0.0%N/A21.9%0.00%
    Universe Pharmaceuticals Inc (UPC)$7.59MN/AN/A-11.0%N/A-1.3%0.00%
    InMed Pharmaceuticals Inc (INM)$8.55MN/AN/A0.0%N/A-26.2%0.00%
    Biofrontera Inc (BFRI)$10.40MN/A0.2x-13.8%-124.6%32.9%0.00%
    Purple Biotech (PPBT)$2.65MN/AN/A0.0%-156.2%0.0%0.00%
    BioCryst Pharmaceuticals Inc (BCRX)$1.96B4.4x2.0x-37.4%24937.1%13.1%0.00%
    PharmaCyte Biotech Inc (PMCB)$3.77MN/AN/A0.0%N/A0.0%0.00%
    Peer median$4.55M4.4x1.8x0.0%-56.1%16.9%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Sunshine Biopharma, ranked by how closely their business, size, sector and industry match. The largest group, 10 of the 12, is in Drug Manufacturers - Specialty & Generic; the other 2 are in Biotechnology.

    CompanyAboutPeers
    Redhill Biopharma Ltd (RDHL)Drug Manufacturers - Specialty & Generic
    RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focused on gastrointestinal and infectious diseases.
    PRF Technologies Ltd. (PRFX)Drug Manufacturers - Specialty & Generic
    PainReform Ltd., a pharmaceutical company specializing in clinical stages, is dedicated to the development of therapies that provide an extended period...
    cbdMD Inc (YCBD)Drug Manufacturers - Specialty & Generic
    cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company is headquartered in Charlotte, North Carolina.
    YCBD competitors
    Sonoma Pharmaceuticals Inc (SNOA)Drug Manufacturers - Specialty & Generic
    Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for various applications, including wound care...
    SNOA competitors
    Gelteq Limited Ordinary Shares (GELS)Drug Manufacturers - Specialty & Generic
    Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals.
    Akanda Corp (AKAN)Drug Manufacturers - Specialty & Generic
    Akanda Corporation. The company is headquartered in New Romney, the United Kingdom.
    Universe Pharmaceuticals Inc (UPC)Drug Manufacturers - Specialty & Generic
    Universe Pharmaceuticals INC, a pharmaceutical company, is engaged in the manufacture, marketing...
    InMed Pharmaceuticals Inc (INM)Drug Manufacturers - Specialty & Generic
    InMed Pharmaceuticals Inc., a clinical-stage pharmaceutical company, researches and develops cannabinoid-based therapies.
    Biofrontera Inc (BFRI)Drug Manufacturers - Specialty & Generic
    Biofrontera Inc., a biopharmaceutical company, develops and supplies dermatological products for the treatment of skin conditions in the United States.
    BFRI competitors
    Purple Biotech (PPBT)Biotechnology
    Purple Biotech Ltd., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs in the United...
    PPBT competitors
    BioCryst Pharmaceuticals Inc (BCRX)Drug Manufacturers - Specialty & Generic
    BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small molecule drugs. The company is headquartered in Durham, North Carolina.
    BCRX competitors
    PharmaCyte Biotech Inc (PMCB)Biotechnology
    PharmaCyte Biotech, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cell therapies for cancer and diabetes in the United...
    PMCB competitors

    Frequently Asked Questions About SBFM

    Who are Sunshine Biopharma's main competitors?

    The companies most similar to Sunshine Biopharma include Redhill Biopharma (RDHL), PRF Technologies (PRFX), cbdMD (YCBD), Sonoma Pharmaceuticals (SNOA) and Gelteq Limited Ordinary Shares (GELS), listed from the closest match.

    Who is Sunshine Biopharma's biggest competitor?

    BioCryst Pharmaceuticals (BCRX) is the largest of the similar companies at $1.96B; Redhill Biopharma (RDHL) is the closest match by business profile, size, sector and industry.

    How does SBFM stock compare with its competitors?

    SBFM's net margin is -17.4% against a peer median of 0.0%.

    Which of Sunshine Biopharma's competitors pays a higher dividend?

    Sunshine Biopharma pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Sunshine Biopharma bigger than its competitors?

    No. Sunshine Biopharma is 13th by market cap among the 13 companies on this page; the largest is BioCryst Pharmaceuticals (BCRX) at $1.96B.